Mark White

Mark
White

Executive Chairman
Treidlia Biovet
LinkedIn 
View profile
Biography
Veterinarian with experience in intensive livestock industries. PhD in microbiology. Founder and owner of Treidlia Biovet, veterinary vaccine manufacturer in Sydney Australia.
Research interests
Broad sweep of vaccinology
Discipline
Bacteriology Bio-manufacturing Cellular biology Challenge model development Clinical trials – efficacy Clinical trials – safety Commercialisation Deployment Epidemiology Formulation technology Molecular biology Pharmacovigilance Protein biology QC test development Quality assurance Registration Regulation Safety evaluation Virology
Host species
Cattle Dogs Fish Horses Pigs Poultry Small ruminants Wildlife
Pathogen
Bacteria BacteriaAeromonas BacteriaChlamydophila BacteriaE. coli BacteriaErysipelas BacteriaLeptospira BacteriaMycoplasma BacteriaSalmonella BacteriaYersinia Parasites ParasitesEimeria ParasitesNematodes ParasitesTheileria annulata ParasitesTheileria parva ParasitesTicks Viruses VirusesAfrican swine fever virus VirusesCalicivirus VirusesInfectious bursal disease virus VirusesInfectious pancreatic necrosis virus VirusesInfectious salmon anaemia virus VirusesMareks disease virus VirusesNewcastle disease virus VirusesParamyxoviruses VirusesPoxviruses VirusesRotavirus
Stage of vaccine development
Adjuvants Antigen discovery and immunogen design Clinical trials Commercialisation Correlates of protection – immunomonitoring Deployment Field trials Marketing Pre-clinical trials Vaccine delivery